JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
54 hedge funds and large institutions have $37.3M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $42.2M → $37.3M (-$4.83M)
Holders
54
Holding in Top 10
–
Calls
$31K
Puts
$8K
Top Buyers
| 1 | +$1.04M | |
| 2 | +$757K | |
| 3 | +$672K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$496K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$381K |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$1.19M | |
| 3 | -$671K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$255K |
| 5 |
PP
PDT Partners
New York
|
-$224K |